Site-selective reactions with peptide-based catalysts

Topics in Current Chemistry

Volumn 372, Issue , 2015, Pages 157-202

  Giuliano, Michael W ^a   Miller, Scott J ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

Asymmetric synthesis; Catalysis; Natural products; Peptides; Site selective reactions

Indexed keywords

APOPTOLIDIN A; ERYTHROMYCIN; GLYCOPEPTIDE; MACROLIDE; PEPTIDE; PYRONE DERIVATIVE;

CATALYSIS; CHEMISTRY; OXIDATION REDUCTION REACTION; PHOSPHORYLATION;

CATALYSIS; ERYTHROMYCIN; GLYCOPEPTIDES; MACROLIDES; OXIDATION-REDUCTION; PEPTIDES; PHOSPHORYLATION; PYRONES;

EID: 84959353921     PISSN: 03401022     EISSN: None     Source Type: Book Series    
DOI: 10.1007/128_2015_653     Document Type: Article

References (199)

1. Matsumoto M, Lee SJ, Gagne MR, Waters ML (2014) Cross-strand histidine-aromatic interactions enhance acyl-transfer rates in beta-hairpin peptide catalysts. Org Biomol Chem 12:8711–8718
2. Matsumoto M, Lee SJ, Waters ML, Gagne MR (2014) A catalyst selection protocol that identifies biomimetic motifs from β-hairpin libraries. J Am Chem Soc 136:15817–15820
3. Julia S, Masana J, Vega JC (1980) “Synthetic enzymes”. Highly stereoselective epoxidation of a chalcone in a triphasic toluene-water-poly[(S)-alanine] system. Angew Chem Int Ed 19:929–931
4. Porter MJ, Roberts SM, Skidmore J (1999) Polyamino acids as catalysts in asymmetric synthesis. Bioorg Med Chem 7:2145–2156
5. Jarvo ER, Miller SJ (2002) Amino acids and peptides as asymmetric organocatalysts. Tetrahedron 58:2481–2495
6. Miller SJ (2004) In search of peptide-based catalysts for asymmetric organic synthesis. Acc Chem Res 37:601–610
7. Colby Davie EA, Mennen SM, Xu Y, Miller SJ (2007) Asymmetric catalysis mediated by synthetic peptides. Chem Rev 107:5759–5812
8. Wenemers H (2011) Asymmetric catalysis with peptides. Chem Commun 47:12036–12041
9. Lewandowski B, Wennemers H (2014) Asymmetric catalysis with short-chain peptides. Curr Opin Chem Biol 22:40–46
10. Kagan HB, Fiaud JC (1979) New approaches in asymmetric synthesis. In: Eliel EL, Allinger NL (eds) Topics in stereochemistry, vol 10. Wiley, Hoboken, pp 175–285
11. Kagan HB, Fiaud JC (1988) Kinetic resolution. In: Eliel EL, Wilen SH (eds) Topics in stereochemistry, vol 18. Wiley, Hoboken, pp 249–330
12. Fenwick DR, Kagan HB (1999) Asymmetric amplification. In: Denmark SE (ed) Topics in stereochemistry, vol 122. Wiley, Hoboken, pp 257–296
13. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (2002) The protein kinase complement of the human genome. Science 298:1912–1934
14. Krebs EG (1983) Historical perspectives on protein phosphorylation and a classification system for protein kinases. Philos Trans R Soc Lond B Biol Sci 302:3–11
15. Demchenko AV (ed) (2008) Handbook of chemical glycosylation: advances in stereoselectivity and therapeutic relevance. Wiley-VCH, Weinheim
16. Ernst B, Hart GW, Sinay P (2000) Protecting groups: effects on reactivity, glycosylation stereoselectivity, and coupling efficiency. In: Green LG, Ley SV (eds) Carbohydrates in chemistry and biology. Wiley-VCH, Weinheim
17. Fischer E (1914) Über Phosphorsäureester des Methyl-glucosids und Theophyllin-glucosids. Ber Chem 47:3193–3205
18. Moffatt JG, Khorana HG (1957) Carbodiimides. VII. Tetra-p-nitrophenyl pyrophosphate, a new phosphorylating agent. J Am Chem Soc 79:3741–3746
19. Chambers RW, Moffatt JG, Khorana HG (1957) Nucleoside polyphosphates. IV. A new synthesis of guanosine-50-phosphate. J Am Chem Soc 79:3747
20. Sculimbrene BR, Miller SJ (2001) Discovery of a catalytic asymmetric phosphorylation through selection of a minimal kinase mimic: a concise total synthesis of D-myo-inositol-1- phosphate. J Am Chem Soc 123:10125–10126
21. Sculimbrene BR, Morgan AJ, Miller SJ (2002) Enantiodivergence in small-molecule catalysis of asymmetric phosphorylation: concise total syntheses of the enantiomeric D-myoinositol- 1-phosphate and D-myo-inositol-3-phosphate. J Am Chem Soc 124:11653–11656
22. Sculimbrene BR, Morgan AJ, Miller SJ (2003) Nonenzymatic peptide-based catalytic asymmetric phosphorylation of inositol derivatives. Chem Commun 1781–1785
23. Agranoff BW, Fisher SK (1991) Inositol phosphates and derivatives: synthesis, biochemistry, and therapeutic potential. In Reitz AB (ed) ACS Symposium series 463, American Chemical Society, Washington, p 20
24. Billington DC (1993) The inositol phosphates: chemical synthesis and biological significance. VCH, New York
25. Pirrung MC (1999) Histidine kinases and two-component signal transduction systems. Chem Biol 121:11638–11643
26. Kee JM, Muir TW (2012) Chasing phosphohistidine, an elusive sibling in the phosphoamino acid family. ACS Chem Biol 7:44–51
27. Copeland GT, Miller SJ (2001) Selection of enantioselective acyl transfer catalysts from a pooled peptide library through a fluorescence-based activity assay: an approach to kinetic resolution of secondary alcohols of broad structural scope. J Am Chem Soc 123:6496–6502
28. Jarvo ER, Copeland GT, Papaioannou N, Bonitatebus PJ, Miller SJ (1999) A biomimetic approach to asymmetric acyl transfer catalysis. J Am Chem Soc 121:11638–11643
29. Billington DC, Baker R, Kulagowski JJ, Mawer IM, Vacca JP, deSolms SJ, Huff JR (1989) The total synthesis of myo-inositol phosphates via myo-inositol orthoformate. J Chem Soc Perkin Trans 1:1423–1429
30. Irvine RF, Schell MJ (2001) Back in the water: the return of the inositol phosphates. Nat Rev Mol Cell Biol 2:327–338
31. Prestwich GD (2004) Phosphoinositide signaling: from affinity probes to pharmaceutical targets. Chem Biol 11:619–637
32. Di Paolo G, de Camilli P (2006) Phosphoinositides in cell regulation and membrane dynamics. Nature 443:651–657
33. Sculimbrene BR, Xu Y, Miller SJ (2004) Asymmetric syntheses of phosphatidylinositol-3- phosphates with saturated and unsaturated side chains through catalytic asymmetric phosphorylation. J Am Chem Soc 126:13182–13183
34. Morgan AJ, Wang YK, Roberts MF, Miller SJ (2004) Chemistry and biology of deoxy-myoinositol phosphates: stereospecificity of substrate interactions within an archaeal and a bacterial IMPase. J Am Chem Soc 126:15370–15371
35. Morgan AJ, Komiya S, Xu Y, Miller SJ (2006) Unified total syntheses of the inositol polyphosphates: D-I-3,5,6P3, D-I-3,4,5P3, and D-I-3,4,5,6P4 via catalytic enantioselective and site-selective phosphorylation. J Org Chem 71:6923–6931
36. Xu Y, Sculimbrene BR, Miller SJ (2006) Streamlined synthesis of phosphatidylinositol (PI), PI3P, PI3,5P2, and deoxygenated analogues as potential biological probes. J Org Chem 71:4919–4928
37. Longo CM, Wei Y, Roberts MF, Miller SJ (2009) Asymmetric syntheses of L, L- and L, D-di-myo-inositol-1,10-phosphate and their behavior as stabilizers of enzyme activity at extreme temperatures. Angew Chem Int Ed 48:4158–4161
38. Cuilla R, Burrgraf S, Stetter KO, Roberts MF (1994) Occurrence and role of di-myo-inositol- 1,10-phosphate in Methanococcus igneus. Appl Environ Microbiol 60:3660–3664
39. Chen L, Spiliotis ET, Roberts MF (1998) Biosynthesis of di-myo-inositol-1,10-phosphate, a novel osmolyte in hyperthermophilic Archaea. J Bacteriol 180:3785–3792
40. Chandler BD, Burkhardt AL, Foley K, Cullis C, Driscoll D, D’Amore NR, Miller SJ (2014) A fully synthetic and biochemically validated phosphatidyl inositol-3-phosphate hapten via asymmetric synthesis and native chemical ligation. J Am Chem Soc 136:412–418
41. Harris JR, Markl J (1999) Keyhole limpet hemocyanin (KLH): a biomedical review. Micron 6:597–623
42. Harlow E, Lane D (1988) Antibodies: a laboratory manual. Cold Spring Harbor, New York, Chapter 5
43. Hermanson GT (2008) Bioconjugate techniques, 2nd edn. Academic, New York, Chapter 19
44. Martin SF, Josey JA, Wong YL, Dean DW (1994) General method for the synthesis of phospholipid derivatives of 1,2-O-diacyl-sn-glycerols. J Org Chem 59:4805–4820
45. Dawson PE, Muir TW, Clark-Lewis I, Kent SBH (1994) Synthesis of proteins by native chemical ligation. Science 266:776–779
46. Johnson ECB, Kent SBH (2006) Insights into the mechanism and catalysis of the native chemical ligation reaction. J Am Chem Soc 128:6640–6646
47. Nilsson BL, Soellner MB, Raines RT (2005) Chemical synthesis of proteins. Annu Rev Biophys Biomol Struct 34:91–118
48. Fang GM, Cui HK, Zheng JS, Liu L (2010) Chemoselective ligation of peptide phenyl esters with N-terminal cysteines. ChemBioChem 11:1061–1065
49. Lewis CA, Sculimbrene BR, Xu Y, Miller SJ (2005) Desymmetrization of glycerol derivatives with peptide-based acylation catalysts. Org Lett 7:3021–3023
50. Griswold KS, Miller SJ (2003) A peptide-based catalyst approach to regioselective functionalization of carbohydrates. Tetrahedron 59:8869–8875
51. Evans JW, Fierman MB, Miller SJ, Ellman JA (2004) Catalytic enantioselective synthesis of sulfinate esters through the dynamic resolution of tert-butanesulfinyl chloride. J Am Chem Soc 126:8134–8135
52. Schreiber SL, Schreiber TS, Smith DB (1987) Reactions that proceed with a combination of enantiotopic group and diastereotopic face selectivity can deliver products with very high enantiomeric excess: experimental support of a mathematical model. J Am Chem Soc 109:1525–1529
53. Kawabata T, Nagato M, Takasu K, Fuji K (1997) Nonenzymatic kinetic resolution of racemic alcohols through an “induced fit” process. J Am Chem Soc 119:3169–3170
54. Kawabata T, Yamamoto K, Momose Y, Yoshida H, Nagaoka Y, Fuji K (2001) Kinetic resolution of amino alcohol derivatives with a chiral nucleophilic catalyst: access to enantiopure cyclic cis-amino alcohols. Chem Commun 2700–2701
55. Kawabata T, Muramatsu W, Nishio T, Shibata T, Schedel H (2007) A catalytic one-step process for the chemo- and regioselective acylation of monosaccharides. J Am Chem Soc 129:12890–12895
56. Ueda Y, Muramatsu W, Mishiro K, Furuta T, Kawabata T (2009) Functional group tolerance in organocatalytic regioselective acylation of carbohydrates. J Org Chem 74:8802–8805
57. Williamson CL, Chan L, Taylor MS (2012) Regioselective, borinic acid-catalyzed monoacylation, sulfonylation, and alkylation of diols and carbohydrates: expansion of substrate and mechanistic studies. J Am Chem Soc 134:8260–8267
58. Taylor MS (2015) Catalysis based on reversible covalent interactions of organoboron compounds. Acc Chem Res 48:295–305
59. Sun X, Lee H, Lee S, Tan KL (2013) Catalyst recognition of cis-1,2-diols enables siteselective functionalization of complex molecules. Nat Chem 5:790–795
60. Manville N, Alite H, Haeffner F, Hoveyda AH, Snapper ML (2013) Enantioselective silyl protection of alcohols promoted by a combination of chiral and achiral Lewis basic catalysts. Nat Chem 5:768–774
61. Blaisdell TP, Lee S, Kasaplar P, Sun X, Tan KL (2013) Practical silyl protection of ribonucleosides. Org Lett 15:4710–4713
62. Sun X, Worthy AD, Tan KL (2013) Resolution of terminal 1,2-diols via silyl transfer. J Org Chem 78:10494–10499
63. Sun X, Lee H, Lee S, Tan KL (2013) Catalyst recognition of cis-1,2-diols enables siteselective functionalization of complex molecules. Nature Chem 5:790–795
64. Zhao Y, Rodrigo J, Hoveyda AH, Snapper ML (2006) Enantioselective silyl protection of alcohols catalysed by amino-acid-based small molecule. Nature 443:64–70
65. Rawlings BJ (1999) Biosynthesis of polyketides (other than actinomycete macrolides). Nat Prod Rep 16:425–484
66. Shen B (2000) Biosynthesis of aromatic polyketides. Top Curr Chem 209:1–51
67. Newman DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70:461–477
68. Walsh CT (2008) The chemical versatility of natural product assembly lines. Acc Chem Res 41:4–10
69. Cragg GM, Newman DJ (2013) Natural products: a continuing source of novel drug leads. Biochim Biophys Acta 1830:3670–3695
70. Hertweck C (2009) The biosynthetic logic of polyketide diversity. Angew Chem Int Ed 48:4688–4716
71. Schetter B, Mahrwald R (2006) Modern aldol methods for the total synthesis of polyketides. Angew Chem Int Ed 45:7506–7525
72. Dechert-Schmitt AMR, Schmitt DC, Gao X, Itoh T, Krische MJ (2014) Polyketide construction via hydrohydroxyalkylation and related alcohol C-H functionalizations. Reinventing the chemistry of carbonyl addition. Nat Prod Rep 31:504–513
73. Dalby SM, Paterson I (2010) Synthesis of polyketide natural products and analogs as promising anticancer agents. Curr Opin Drug Discov Devel 13:777–794
74. Cane DE, Walsh CT, Khosla C (1998) Harnessing the biosynthetic code: combinations, permutations, and mutations. Science 282:63–68
75. Khosla C, Herschlag D, Cane DE, Walsh CT (2014) Assembly line polyketide synthases: mechanistic insights and unsolved problems. Biochemistry 53:2875–2883
76. Hutchinson CR, Fuji I (1995) Polyketide synthase gene manipulation: a structure-function approach in engineering novel antibiotics. Annu Rev Microbiol 49:201–238
77. Jacobsen JR, Hutchinson CR, Cane DE, Khosla C (1997) Precursor-directed biosynthesis of erythromycin analogs by an engineered polyketide synthase. Science 277:367–369
78. Hertweck C (2015) Decoding and reprogramming complex polyketide assemblylines: prospects for synthetic biology. Trends Biochem Sci 40:189–199
79. Wiley PF, Gerzon K, Flynn EH, Sigal MV, Weaver O, Quarck UC, Chauvette RR, Monahan R (1957) Erythromycin. X. Structure of erythromycin. J Am Chem Soc 79:6062–6070
80. Kim JW, Adachi H, Kazuo SY, Hayakwa Y, Seto H (1997) Apoptolidin, a new apoptosis inducer in transformed cells from Nocardiopsis sp. J Antibiot 50:628–630
81. Taylor RE, Chen Y, Galvin GM, Prabba PK (2004) Conformation-activity relationships in polyketide natural products. Towards to biologically active conformation of epothilone. Org Biomol Chem 2:127–132
82. Larsen EM, Wilson MR, Taylor RE (2015) Conformation-activity relationships of polyketide natural products. Nat Prod Rep 32:1183–1206
83. Wright GD (2005) Bacterial resistance to antibiotics: enzymatic degradation and modification. Adv Drug Deliv Rev 57:1451–1470
84. Walsh CT (2005) Molecular mechanisms that confer antibacterial drug resistance. Nature 406:775–781
85. Peddibhotia S, Dang Y, Liu JO, Romo D (2007) Simultaneous arming and structure/activity studies of natural products employing O-H insertions: an expedient and versatile strategy for natural products-based chemical genetics. J Am Chem Soc 129:12222–12231
86. Robles O, Romo D (2014) Chemo- and site-selective derivatizations of natural products enabling biological studies. Nat Prod Rep 31:318–334
87. Lewis CA, Miller SJ (2006) Site-selective derivatization and remodeling of erythromycin A by using simple peptide-based chiral catalysts. Angew Chem Int Ed 45:5616–5619
88. Lewis CA, Merkel J, Miller SJ (2008) Catalytic site-selective synthesis and evaluation of a series of erythromycin analogs. Bioorg Med Chem Lett 18:6007–6011
89. Jones PH, Perun TJ, Rowley EK, Baker EJ (1972) Chemical modifications of erythromycin antibiotics 3. Synthesis of 400 and 11 esters of erythromycin A and B. J Med Chem 15:631–634
90. Martin YC, Jones PH, Perun TJ, Grundy WE, Bell S, Bower RR, Shipkowitz NL (1972) Chemical modification of erythromycin antibiotics 4. Structure-activity relations of erythromycin esters. J Med Chem 15:635–638
91. Haque TS, Little JC, Gellman SH (1994) ‘Mirror image’ reverse turns promote β-hairpin formation. J Am Chem Soc 116:4105–4106
92. Haque TS, Little JC, Gellman SH (1996) Stereochemical requirements for β-hairpin formation: model studies with four-residue peptides and depsipeptides. J Am Chem Soc 118:6975–6985
93. Gellman SH (1998) Minimal models systems for β-sheet secondary structure in proteins. Curr Opin Chem Biol 2:717–725
94. Davies JS, Everett JR, Hatton IK, Hunt E, Tyler JW, Zomaya II, Slawin AMZ, Williams DJ (1991) NMR spectroscopic and X-ray crystallographic studies on the structure, stereochemistry and conformation of a series of 9,11 cyclic aminals of (9S)-9-N-methylerythromyclamine A. J Chem Soc Perkin Trans 2:201–214
95. Everett JR, Hunt E, Tyler JW (1991) Ketone-hemiacetal tautomerism in erythromycin A in non-aqueous solutions. An NMR spectroscopic study. J Chem Soc Perkin Trans 2:1481–1487
96. Tardrew PL, Mao JCH, Kenney D (1969) Antibacterial activity of 20esters of erythromycin. Appl Microbiol 18:159–165
97. Lewis CA, Longcore KE, Miller SJ, Wender PA (2009) An approach to the site-selective diversification of apoptolidin A with peptide-based catalysts. J Nat Prod 72:1864–1869
98. Wender PA, Gulledge AV, Jankowski OD, Seto H (2002) Isoapoptolidin: structure and activity of the ring-expanded isomer of apoptolidin. Org Lett 4:3819–3822
99. Pennington JD, Williams HJ, Salomon AR, Sulikowski GA (2002) Toward a stable apoptolidin derivative: identification of isoapoptolidin and selective deglycosylation of apoptolidin. Org Lett 4:3823–3825
100. Wender PA, Jankowski OD, Longcore K, Tabet EA, Seto H, Tomikawa T (2006) Correlation of F0F1-ATPase inhibition and antiproliferative activity of apoptolidin analogues. Org Lett 8:589–592
101. Linnane P, Magnus N, Magnus P (1997) Induction of molecular asymmetry by a remote chiral group. Nature 385:799–801
102. Clayden J, Lund A, Vallverdu L, Helliwell M (2004) Ultra-remote stereocontrol by conformational communication of information along a carbon chain. Nature 431:966–971
103. Byrne L, Sola J, Boddaert T, Marcelli T, Adams RW, Morris GA, Clayden J (2014) Foldamer-mediated remote stereocontrol: >1,60 asymmetric induction. Angew Chem Int Ed 53:151–155
104. Lewis CA, Chiu A, Kubryk M, Balsells J, Pollard D, Esser CK, Murry J, Reamer RA, Hansen KB, Miller SJ (2006) Remote desymmetrization at near-nanometer group separation catalyzed by a miniaturized enzyme mimic. J Am Chem Soc 128:16454–16455
105. Lewis CA, Gustafson JL, Chiu A, Balsells J, Pollard D, Murry J, Reamer RA, Hansen KB, Miller SJ (2008) A case of remote asymmetric induction in the peptide-catalyzed desymmetrization of a bis(phenol). J Am Chem Soc 130:16358–16455
106. Hoveyda A, Evans DA, Fu GC (1993) Substrate-directable chemical reactions. Chem Rev 93:1307–1370
107. Yoshimoto FK, Guengerich FP (2014) Mechanism of the third oxidative step in the conversion of androgens to estrogens by cytochrome P450 19A1 steroid aromatase. J Am Chem Soc 136:15016–15025
108. Pallan PS, Nagy LD, Li L, Gonzalez E, Kramlinger VM, Azumaya CM, Waterman MR, Guengerich FP, Egli M, Wawrzak Z (2015) Structural and kinetic basis of steroid 17α,20-lyase activity in teleost fish cytochrome P450 17A1 and its absence in cytochrome P450 17A 2. J Biol Chem 290:3248–3268
109. Payne AH, Hales DB (2004) Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev 25:947–970
110. Barton DHR, McCombie SW (1975) A new method for the deoxygenation of secondary alcohols. J Chem Soc Perkin Trans 1:1574–1585
111. Barton DHR, Blundell P, Dorchak J, Jang DO, Jaszberenyi J (1991) The invention of radical reactions. Part XXI. Simple methods for the radical deoxygenation of primary alcohols. Tetrahedron 47:8969–8984
112. Barton DHR, Dorchak J, Jaszberenyi J (1992) The invention of radical reactions. Part XXIV. Relative rates of acylation and radical deoxygenation of secondary alcohols. Tetrahedron 48:7435–7446
113. Sanchez-Rosello M, Puchlopek ALA, Morgan AJ, Miller SJ (2008) Site-selective catalysis of phenyl thionoformate transfer as a tool for regioselective deoxygenation of polyols. J Org Chem 73:1774–1782
114. Jordan PA, Kayser-Bricker KJ, Miller SJ (2010) Asymmetric phosphorylation through catalytic P(III) phosphoramidite transfer: enantioselective synthesis of D-myo-inositol-6- phosphate. Proc Natl Acad Sci U S A 107:20620–20624
115. Sculimbrene BR (2004). Catalytic asymmetric phosphorylation. Ph.D. thesis. Boston College, Boston
116. Carruthers MH (1991) Chemical synthesis of DNA and DNA analogs. Acc Chem Res 24:278–284
117. Vlasuk GP, Webb TR, Abelman MM, Pearson DA, Miller TA (21, 1999) US Patent 5492895
118. Hayakawa Y, Katoka M (1997) Preparation of short oligonucleotides via the phosphoramidite method using a tetrazole promoter in a catalytic manner. J Am Chem Soc 119:11758–11762
119. Jordan PA, Miller SJ (2012) An approach to the site-selective deoxygenation of hydroxyl groups based on catalytic phosphoramidite transfer. Angew Chem Int Ed 51:2907–2911
120. Zhang L, Koreeda M (2004) Radical deoxygenation of hydroxyl groups via phosphites. J Am Chem Soc 126:13190–13191
121. Fiori KW, Puchlopek ALA, Miller SJ (2009) Enantioselective sulfonylation reactions mediated by a tetrapeptide catalyst. Nat Chem 1:630–634
122. Butler MS, Hansford KA, Blaskovich MAT, Halai R, Cooper MA (2014) Glycopeptide antibiotics: back to the future. J Antibiot 67:631–644
123. Hubbard BK, Walsh CT (2003) Vancomycin assembly: nature’s way. Angew Chem Int Ed 42:730–765
124. Nicolaou KC, Boddy CNC, Brase S, Winissinger N (1999) Chemistry, biology, and medicine of the glycopeptide antibiotics. Angew Chem Int Ed 38:2097–2152
125. Williams DH (1996) The glycopeptide story –how to kill the deadly ‘superbugs.’. Nat Prod Rep 13:469–477
126. Min G, Chen Z, Onishi HR, Kohler J, Silver LL, Kerns R, Fukuzawa S, Thompson C, Kahne D (1999) Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala. Science 284:507–511
127. Kerns R, Dong SD, Fukuzawa S, Carbeck J, Kohler J, Silver LL, Kahne D (2000) The role of hydrophobic substituents in the biological activity of glycopeptide antibiotics. J Am Chem Soc 122:12608–12609
128. Sun B, Chen Z, Eggert US, Shaw SJ, LaTour JV, Kahne D (2001) Hybrid glycopeptide antibiotics. J Am Chem Soc 123:12722–12723
129. Lin H, Walsh CT (2004) A chemoenzymatic approach to glycopeptide antibiotics. J Am Chem Soc 126:13998–14003
130. Leimkuhler C, Chen L, Barrett D, Panzone G, Sun B, Falcone B, Oberthuer M, Walker S, Kahne D (2005) Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics. J Am Chem Soc 127:3250–3251
131. Ashford PA, Bew SP (2012) Recent advances in the synthesis of new glycopeptide antibiotics. Chem Soc Rev 41:957–978
132. Higgins DL, Chang R, Debabov DV, Leung J, Wu T, Krause KM, Sandvik E, Hubbard JM, Kaniga K, Schmidt DE et al (2005) Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 49:1127–1134
133. Zhanel GC, Calic D, Schweizer F, Zelenitsky S, Adam H, Lagace-Wiens PRS, Rubinstein E, Gin AS, Hoban DJ, Karlowsky JA (2010) New lipoglycopeptides: a comparative review of dalbavancin, oritavancin, and telavancin. Drugs 70:859–886
134. Reynolds PE (1989) Structure, biochemistry, and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis 8:943–950
135. Mackay JP, Gerhard U, Beauregard DA, Williams DH, Westwell MS, Searle MS (1994) Glycopeptide antibiotic activity and the possible role of dimerization: a model for biological signaling. J Am Chem Soc 116:4581–4590
136. Dong SD, Oberthuer M, Losey HC, Anderson JW, Eggert US, Peczuh MW, Walsh CT, Kahne D (2002) The structural basis for induction of VanB resistance. J Am Chem Soc 124:9064–9065
137. McComas CC, Crowley BM, Boger DL (2003) Partitioning the loss in vancomycin binding affinity or D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions. J Am Chem Soc 125:9314–9315
138. Crowley BM, Boger DL (2006) Total synthesis and evaluation of [Ψ[CH2NH]Tpg4]vancomycin aglycon: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding. J Am Chem Soc 128:2885–2892
139. Xie J, Pierce JG, James RC, Okano A, Boger DL (2011) A redesigned vancomycin engineered for dual D-Ala-D-Ala and D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria. J Am Chem Soc 133:13946–13949
140. Xie J, Okano A, Pierce JG, James RC, Stamm S, Crane CM, Boger DL (2012) Total synthesis of [Ψ[C(═S)NH]Tpg4]vancomycin aglycon, [Ψ[C(═NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding. J Am Chem Soc 134:1284–1297
141. Bugg TDH, Wright GD, Dutka-Malen S, Arthur M, Courvalin P, Walsh CT (1991) Molecular basis for vancomycin resistance in Enterococus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry 30:10408–10415
142. Walsh CT, Fisher SL, Park IS, Prahalad M, Wu Z (1996) Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story. Chem Biol 3:21–28
143. Walsh CT (1993) Vancomycin resistance: decoding the molecular logic. Science 261:308–309
144. Gray KC, Palacios DS, Dailey I, Endo MM, Uno BE, Wilcock BC, Burke MD (2012) Amphotericin primarily kills yeast by simply binding ergosterol. Proc Natl Acad Sci U S A 109:2234–2239
145. Hanessian S, Giguere A, Grzyb J, Maianti JP, Saavedra OM, Aggen JB, Linsell MS, Goldblum AA, Hildebrandt DJ, Kane TR, Dozzo P, Gliedt MJ, Matias RD, Feeney LA, Armstrong ES (2011) Toward overcoming Staphylococcus aureus aminoglycoside resistance mechanism with a functionally designed neomycin analogue. ACS Med Chem Lett 2:924–928
146. Szpilman AM, Cereghetti DM, Manthorpe JM, Wurtz NR, Carreira EM (2009) Synthesis and biophysical studies on 35-deoxy amphotericin B methyl ester. Chem Eur J 15:7117–7128
147. Fujisawa KL, Hoshiya T, Kawaguchi H (1974) Aminoglycoside antiobiotics. VII. Acute toxicity of aminoglycoside antibiotics. J Antibiot 27:677–681
148. Griffith BR, Krepel C, Fu X, Blanchard S, Ahmed A, Edmiston CE, Thorson JS (2007) Model for antibiotic optimization via neoglycosylation: synthesis of liponeoglycopeptides active against VRE. J Am Chem Soc 129:8150–8155
149. Thompson C, Ge M, Kahne D (1999) Synthesis of vancomycin from the aglycon. J Am Chem Soc 121:1237–1244
150. Fowler BS, Lammerhold KM, Miller SJ (2012) Catalytic site-selective thiocarbonylations and deoxygenations of vancomycin reveal hydroxy-dependent conformational effects. J Am Chem Soc 134:9755–9761
151. Yoganathan S, Miller SJ (2015) Structure diversificiation of vancomycin through peptidecatalyzed, site-selective lipidation: a catalysis-based approach to combat glycopeptideresistant pathogens. J Med Chem 58:2367–2377
152. Fowler BS, Mikochik PJ, Miller SJ (2010) Peptide-catalyzed kinetic resolution of formamides and thioformamides as an entry to nonracemic amines. J Am Chem Soc 132:2870–2871
153. Han S, Miller SJ (2013) Asymmetric catalysis at a distance: catalytic, site-selective phosphorylation of teicoplanin. J Am Chem Soc 135:12414–12421
154. Han S, Le BV, Hajare HS, Baxter RHG, Miller SJ (2014) X-Ray crystal structure of teicoplanin-A2-2 bound to a catalytic peptide sequence via the carrier protein strategy. J Org Chem 79:8550–8556
155. Chan HC, Huang YT, Lyu SY, Huang CJ, Li YS, Liu YC, Chou CC, Tsai MD, Li TL (2011) Regioselective deacetylation based on teicoplanin-complexed Orf2* crystal structures. Mol Biosyst 7:1224–1231
156. Nieto M, Perkins HR (1971) The specificity of combination between ristocetins and peptides related to bacterial cell-wall mucopeptide precursors. Biochem J 124:845–852
157. Economou NJ, Zentner IJ, Lazo E, Jakonicic J, Stojanoff V, Weeks SD, Gratsky KC, Cocklin S, Loll PJ (2013) Structure of the complex between teicoplanin and a bacterial cell-wall peptide: use of a carrier-protein approach. Acta Crystallogr D69:520–533
158. Economou NJ, Nahoum V, Weeks SD, Gratsky KC, Zentner IJ, Townsend TM, Bhuiya MW, Cocklin S, Loll PJ (2012) A carrier protein strategy yields the structure of dalbavancin. J Am Chem Soc 134:4637–4645
159. Muir TW, Sondhi D, Cole PA (1998) Expressed protein ligation: a general method for protein engineering. Proc Natl Acad Sci U S A 95:6705–6710
160. Muir TW (2013) Semisynthesis of proteins by expressed protein ligation. Annu Rev Biochem 72:249–289
161. Gustafson J, Lim D, Miller SJ (2010) Dynamic kinetic resolution of biaryl atropisomers via peptide-catalyzed asymmetric bromination. Science 328:1251–1255
162. Garand E, Kamrath MZ, Jordan PA, Wolk AB, McCoy AB, Miller SJ (2012) Determination of non-covalent docking by IR spectroscopy of cold gas-phase complexes. Science 335:694–698
163. Barrett KT, Miller SJ (2013) Enantioselective synthesis of atropisomeric benzamides through peptide-catalyzed bromination. J Am Chem Soc 135:2963–2966
164. Barrett KT, Metrano AJ, Rablen PR, Miller SJ (2014) Spontaneous transfer of chirality in an atropisomerically enriched two-axis system. Nature 509:71–75
165. Denmark SE, Burk MT (2010) Lewis base catalysis of bromo- and iodolactonization and cycloetherification. Proc Natl Acad Sci U S A 107:20655–20660
166. Pathak TP, Miller SJ (2012) Site-selective bromination of vancomycin. J Am Chem Soc 134:6120–6123
167. Pathak TP, Miller SJ (2013) Chemical tailoring of teicoplanin with site-selective reactions. J Am Chem Soc 135:8415–8422
168. Fu X, Tan CH (2011) Mechanistic considerations of guanidine-catalyzed reactions. Chem Commun 47:8210–8222
169. Anderson KW, Buchwald SL (2005) General catalysts for the Suzuki-Miyaura and Songoashira coupling reactions of aryl chlorides and for the coupling of challenging substrate combinations in water. Angew Chem Int Ed 44:6173–6177
170. Van Temelen EE, Heys JR (1975) Enzymic epoxidation of squalene variants. J Am Chem Soc 97:1252–1253
171. Maayan G, Ward MD, Kirshenbaum K (2009) Folded biomimetic oligomers for enantioselective catalysis. Proc Natl Acad Sci U S A 106:13679–13684
172. Berkessel A, Koch B, Toniolo C, Rainaldi M, Broxterman QB, Kaptein B (2006) Asymmetric enone epoxidation by short solid-phase bound peptides: further evidence for catalyst helicity and catalytic activity of individual peptide strands. Biopolymers 84:90–96
173. Formagio F, Boncio M, Crisma M, Peggion C, Mezzato S, Polese A, Barazza A, Antonello S, Maran F, Broxterman QB, Kaptein B, Kamphuis J, Vitale RM, Saviano M, Benedetti E, Toniolo C (2002) Nitroxyl peptides as catalysts of enantioselective oxidations. Chem Eur J 8:84–93
174. Peris G, Jakobsche CE, Miller SJ (2007) Aspartate-catalyzed asymmetric epoxidation reactions. J Am Chem Soc 129:8710–8711
175. Jakobsche CE, Peris G, Miller SJ (2008) Functional analysis of an aspartate-based epoxidation catalyst with amide-to-alkene peptidomimetic catalyst analogues. Angew Chem Int Ed 120:6809–6813
176. Kolundzic F, Noshi MN, Tjandra M, Movassaghi M, Miller SJ (2011) Chemoselective and enantioselective oxidation of indoles employing aspartyl peptide catalysts. J Am Chem Soc 133:9104–9111
177. Mercado-Marin EV, Garcia-Reynaga P, Romminger S, Pimenta EF, Romney DK, Lodewyk MW, Williams DE, Andersen RJ, Miller SJ, Tantillo DJ, Berlinck RGS, Sarpong R (2014) Total synthesis and isolation of citrinalin and cyclopiamine congeners. Nature 509:293–294
178. Gnanadesikan V, Corey EJ (2008) A strategy for position-selective epoxidation of polyprenols. J Am Chem Soc 130:8089–8093
179. Chang S, Lee NH, Jacobsen EN (1993) Regio- and enantioselective catalytic epoxidation of conjugated polyenes. Formal synthesis of LTA4 methyl ester. J Org Chem 58:6939–6941
180. Burke CP, Shi Y (2006) Regio- and enantioselective epoxidation of dienes by a chiral dioxirane: synthesis of optically active vinyl cis-epoxides. Angew Chem Int Ed 45:4475–4478
181. Barlan AU, Baak A, Yamamoto H (2006) Enantioselective oxidation of olefins catalyzed by a chiral bishydroxamic acid complex of molybdenum. Angew Chem Int Ed 45:5849–5852
182. Lichtor PA, Miller SJ (2012) Combinatorial evolution of site- and enantioselective catalysts for polyene epoxidation. Nat Chem 4:990–995
183. Lichtor PA, Miller SJ (2014) Experimental lineage and functional analysis of a remotely directed peptide epoxidation catalyst. J Am Chem Soc 136:5301–5308
184. Abascal NC, Lichtor PA, Giuliano MW, Miller SJ (2014) Function-oriented investigations of a peptide-based catalyst that mediates enantioselective allylic alcohol epoxidation. Chem Sci 5:4504–4511
185. Lichtor PA, Miller SJ (2011) One-bead-one-catalyst approach to aspartic acid-based oxidation catalyst discovery. ACS Comb Sci 13:321–326
186. Brustad EM, Arnold FH (2011) Optimizing non-natural protein function with directed evolution. Curr Opin Chem Biol 15:201–210
187. Foo K, Usui I, Gotz DCG, Werner EW, Holte D, Baran PS (2012) Scalable, enantioselective synthesis of germacrenes and related sesquiterpenes inspired by terpene cyclase phase logic. Angew Chem Int Ed 51:11491–11495
188. Yoon TP, Jacobsen EN (2003) Privileged chiral catalysts. Science 299:1691–1693
189. Breslow R, Gellman SH (1983) Intramolecular nitrene C-H insertions mediated by transitionmetal complexes as nitrogen analogues of cytochrome P-450 reactions. J Am Chem Soc 105:6729–6730
190. Breslow R, Gellman SH (1982) Tosylamidation of cyclohexane by a cytochrome P-450 model. J Chem Soc Chem Commun 1400–1401
191. Breslow R (1980) Biomimetic control of chemical selectivity. Acc Chem Res 13:170–177
192. Xu D, Crispino GA, Sharpless KB (1992) Selective asymmetric dihydroxylation (AD) of dienes. J Am Chem Soc 114:7570–7571
193. Becker H, Soler MA, Sharpless KB (1995) Selective asymmetric dhihydroxylation of polyenes. Tetrahedron 51:1345–1376
194. Kolb HC, VanNieuwenhze MS, Sharpless KB (1994) Catalytic asymmetric dihydroxylation. Chem Rev 94:2483–2547
195. Jacobsen EN, Pfaltz A, Yamamoto H (eds) (1999) Comprehensive asymmetric catalysis, vol I–III and Supplement 1. Springer, New York
196. Chen MS, White MC (2007) A predictably selective aliphatic C-H oxidation reaction for complex molecule synthesis. Science 318:783–787
197. Newhouse T, Baran PS (2011) If C-H bonds could talk: selective C-H bond oxidation. Angew Chem Int Ed 50:3362–3374
198. Vohidov F, Coughlin JM, Ball ZT (2015) Rhodium(II) metallopeptie catalyst design enables fine control in selective functionalization of natural SH3 domains. Angew Chem Int Ed 54:4587–4591
199. Ball ZT (2012) Designing enzyme-like catalysts: a rhodium(II) metallopeptide case study. Acc Chem Res 46:560–570